Inicio › Linfoma de Burkitt › Ohio › Cincinnati
Ensayos clínicos de Linfoma de Burkitt en Cincinnati, OH
13 estudios para Linfoma de Burkitt buscan participantes en centros de Cincinnati y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
A Study of CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia (B ALL) and Aggressive Mature B-cell Non-Hodgkin Lymphoma (B NHL)
ReclutandoFase 1
- Cincinnati Children's Hospital, Cincinnati
Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia
ReclutandoFase 2
- University of Cincinnati Cancer Center-UC Medical Center, Cincinnati
- University of Cincinnati Cancer Center-West Chester, West Chester · A 15 mi de distancia
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
ReclutandoFase 2
- Cincinnati Children's Hospital Medical Center, Cincinnati
A Study of Fludarabine Dosing in Children and Young Adults With B-cell Acute Lymphoblastic Leukemia
ReclutandoFase 3
- Cincinnati Children's Hospital Medical Center, Cincinnati
Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
ReclutandoFase 3
- University of Cincinnati Cancer Center-UC Medical Center, Cincinnati
- University of Cincinnati Cancer Center-West Chester, West Chester · A 15 mi de distancia
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
ReclutandoEstudio observacional
- Cincinnati Children's Hospital Medical Center, Cincinnati
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
ReclutandoFase 2
- Cincinnati Children's Hospital Medical Center, Cincinnati
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
ReclutandoFase 2
- Cincinnati Children's Hospital Medical Center, Cincinnati
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
ReclutandoFase 3
- University of Cincinnati Medical Center, Cincinnati
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
ReclutandoFase 3
- Cincinnati Children's Hospital Medical Center, Cincinnati
Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL
ReclutandoFase 2
- Cincinnati Children's Hospital Medical Center, Cincinnati
Study of Inotuzumab Ozogamicin, Venetoclax, and Dexamethasone for Relapsed B-cell ALL
ReclutandoFase 1
- Cincinnati Children's Hospital Medical Center, Cincinnati
Study of VIP943 in Subjects With Advanced CD123+ Hematologic Malignancies
ReclutandoFase 1
- University of Cincinnati, Cincinnati
Ensayos de Linfoma de Burkitt en otras ciudades
- Houston, TX20 estudios
- Milwaukee, WI16 estudios
- Chicago, IL15 estudios
- Philadelphia, PA15 estudios
- Seattle, WA14 estudios
- Atlanta, GA13 estudios
- New York City, NY13 estudios
- Los Angeles, CA10 estudios
- Baldwin Park, CA10 estudios
- Aurora, CO10 estudios
- Durham, NC10 estudios
- Kansas City, MO10 estudios
Otros estudios en Cincinnati
- Cáncer de pulmón de células no pequeñas31 estudios
- Cáncer (todos los tipos)26 estudios
- Cáncer de seno24 estudios
- Fallo cardíaco22 estudios
- Cáncer metastásico21 estudios
- Cáncer del colon y del recto20 estudios
- Obesidad20 estudios
- Leucemia mielógena aguda20 estudios
- Cáncer de próstata19 estudios
- Cáncer de ovario18 estudios
- Cáncer de pulmón18 estudios
- Mieloma múltiple17 estudios
De ClinicalTrials.gov, datos obtenidos el 15 nov 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.